Renalytix (RENX) Stock Statistics & Valuation Metrics

Renalytix has a market cap or net worth of £10.05M. The enterprise value is 26.40M .

Renalytix has 437,018,680 shares outstanding. The number of shares has decreased by -2.65% in one year.

Renalytix’s return on equity (ROE) is 2.91 and return on invested capital (ROIC) is -1238.11%.

The current PE Ratio of Renalytix is ―. Renalytix’s PEG ratio is 0.01.

In the last 12 months, Renalytix had revenue of 3.00M and earned -20.40M in profits. Earnings per share was -0.21.

In the last 12 months, operating cash flow was -23.02M and capital expenditures -4.00K, giving a free cash flow of -23.02M billion.

Renalytix pays an annual dividend of ―, resulting in a dividend yield of ―

Renalytix upcoming earnings date is Nov 3, 2026, TBA (Confirmed).

Renalytix as a current ratio of 1.21, with Debt / Equity ratio of -108.67%

In the past 12 months, Renalytix has paid -1.40M in taxes.

Renalytix EV to EBITDA ratio is -0.68, with an EV/FCF ratio of -0.80.

Renalytix has £9.63M in cash and marketable securities with £8.21M in debt, giving a net cash position of £1.42M billion.

Gross margin is 6.82%, with operating margin of -573.33%, and net profit margin of -680.00%.

The average price target for Renalytix is ―, which is 11.43% higher than the current price. The consensus rating is ―